Insider Transactions in Q2 2025 at Arvinas, Inc. (ARVN)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2025
|
Sunil Agarwal Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,025
+34.69%
|
-
|
|
Jun 25
2025
|
Alsup Laurie Smaldone Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,025
+38.09%
|
-
|
|
Jun 25
2025
|
Edward Moore Kennedy Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,025
+28.9%
|
-
|
|
Jun 25
2025
|
Linda Bain Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,025
+38.09%
|
-
|
|
Jun 25
2025
|
John D Young Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,025
+38.09%
|
-
|
|
Jun 25
2025
|
Briggs Morrison Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,025
+25.83%
|
-
|
|
Jun 25
2025
|
Leslie V Norwalk Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,025
+38.09%
|
-
|
|
Jun 25
2025
|
Everett Cunningham Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,025
+38.09%
|
-
|
|
Jun 24
2025
|
Andrew Saik Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,700
-3.35%
|
$39,900
$7.61 P/Share
|
|
Jun 17
2025
|
Angela M Cacace Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,583
-1.65%
|
$18,081
$7.49 P/Share
|
|
May 09
2025
|
Noah Berkowitz Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,600
+26.0%
|
-
|
|
May 09
2025
|
Angela M Cacace Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,600
+27.54%
|
-
|
|
May 09
2025
|
Andrew Saik Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,600
+25.95%
|
-
|
|
May 09
2025
|
David K Loomis Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,825
+27.82%
|
-
|